Antibiotice S.A. (BVB: ATB)

Market Cap	1.71B
Revenue (ttm)	657.89M
Net Income (ttm)	92.29M
Shares Out	671.34M
EPS (ttm)	0.14
PE Ratio	18.48
Forward PE	n/a
Dividend	0.08 (3.26%)
Ex-Dividend Date	Sep 23, 2024

Volume	415,205
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	1.360 - 3.440
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 24, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania. The company produces medicines for a range of therapeutic areas, such as cardiovascular system, alimentary tract and metabolism, musculo-skeletal system, nervous system, antiinfectives, respiratory system, dermatological, food supplements, sensory organs, genito-urinary apparatus and sexual hormones, varia, and blood and blood forming organs, as well as veterinary medicinal products. It offers its products in the form of sterile injectable powders, capsules, tablets, ointments, ...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,352
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2023, Antibiotice's revenue was 615.29 million, an increase of 21.84% compared to the previous year's 505.00 million. Earnings were 81.09 million, an increase of 57.54%.